Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

With the two active components, sitagliptin and metformin, Janumet has a comprehensive mechanism of action that targets all three key defects of T2DM for improved glycemic control: diminished ...

People taking medications to help manage type 2 diabetes should talk to their doctor about their risk of a rare genital ...

Expert Rev Endocrinol Metab. 2008;3(1):13-19. © 2008 Future Drugs Ltd. Cite this: Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor ...